Skip to main content

Published locations for Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL

User login

  • Reset your password
  • /content/allo-hsct-plus-monoclonal-antibody-treatment-can-improve-survival-patients-r/r-b-all
  • /hematologynews/article/237650/transplant/allo-hsct-plus-monoclonal-antibody-treatment-can-improve
  • /oncologypractice/article/237650/transplant/allo-hsct-plus-monoclonal-antibody-treatment-can-improve
  • /hematology-oncology/article/237650/transplant/allo-hsct-plus-monoclonal-antibody-treatment-can